Omnix 200 DT Tablet contains Cefixime 200 mg, a third-generation cephalosporin antibiotic with broad-spectrum activity against various gram-positive and gram-negative bacteria. It is indicated for the treatment of infections caused by susceptible strains, including uncomplicated urinary tract infections, acute otitis media, pharyngitis, tonsillitis, bronchitis, and uncomplicated gonorrhea. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The tablet is designed as a dispersible formulation, facilitating ease of administration, especially in pediatric and geriatric patients. Omnix 200 DT is absorbed orally with good bioavailability and achieves therapeutic concentrations in various body tissues and fluids. It is generally well tolerated; however, hypersensitivity reactions, gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort may occur. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Dose adjustment may be necessary in renal impairment. The use of Omnix 200 DT should be guided by culture and sensitivity results to minimize the development of resistance. It is essential to complete the full prescribed course to ensure eradication of the infection and prevent relapse. Omnix 200 DT should be stored in a cool, dry place, away from direct sunlight.